What is Harvard Apparatus Regenerative Technology PB Ratio?
Harvard Apparatus Regenerative TechnologyHRGN 27 PB Ratio is 210.00 as of Jul. 11, 2026, which is 1552% above its 10-year median of 12.71. GuruFocus rates HRGN with a GF Scoreâ„¢ of 27/100 and a GF Valueâ„¢ of $5.34 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,894 Consumer Packaged Goods companies, Harvard Apparatus Regenerative Technology ranks worse than 99.74% on this metric.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Harvard Apparatus Regenerative Technology was 561.80% per year. The lowest was -69.10% per year. And the median was -53.10% per year.
Back to Basics: PB Ratio
Harvard Apparatus Regenerative Technology (OTCPK:HRGN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Harvard Apparatus Regenerative Technology PB Ratio Related Terms
Harvard Apparatus Regenerative Technology PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Apparatus Regenerative Technology PB Ratio Chart
Harvard Apparatus Regenerative Technology Annual Data
For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harvard Apparatus Regenerative Technology PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's PB Ratio distribution charts can be found below:
* The bar in red indicates where Harvard Apparatus Regenerative Technology's PB Ratio falls into.
Harvard Apparatus Regenerative Technology PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Harvard Apparatus Regenerative Technology (HRGN) has a PB Ratio of 210.00 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Harvard Apparatus Regenerative Technology and its competitors. This is 1552% above median its historical median of 12.71. Over the past decade, Harvard Apparatus Regenerative Technology's PB Ratio has ranged from 2.13 to 335.48. According to the industry distribution chart, Harvard Apparatus Regenerative Technology ranks #1889 out of 1894 companies in the Consumer Packaged Goods industry, placing it in the top 99.7%.
Is Harvard Apparatus Regenerative Technology's PB Ratio too high?
Harvard Apparatus Regenerative Technology's current PB Ratio of 210.00 is 1552% above median its 10-year median of 12.71. Over the past 10 years, this metric has ranged from a low of 2.13 to a high of 335.48. The Consumer Packaged Goods industry median PB Ratio is 1.36. Harvard Apparatus Regenerative Technology's value of 210.00 is 15341.2% above this industry median. Based on the distribution chart, Harvard Apparatus Regenerative Technology ranks #1889 out of 1894 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Harvard Apparatus Regenerative Technology has a GF Scoreâ„¢ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's PB Ratio compare to DTEAF and STCB?
According to the Consumer Packaged Goods industry distribution chart, Harvard Apparatus Regenerative Technology ranks #1889 out of 1894 companies for PB Ratio. This places Harvard Apparatus Regenerative Technology in the lower half of its industry. The industry median PB Ratio is 1.36. Harvard Apparatus Regenerative Technology's value of 210.00 is 15341.2% above this benchmark. Historically, Harvard Apparatus Regenerative Technology's own PB Ratio has ranged from 2.13 to 335.48 over the past decade. While the company's 10-year median is 12.71 vs. the industry median of 1.36, Harvard Apparatus Regenerative Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.36, based on 1,894 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Harvard Apparatus Regenerative Technology's current PB Ratio of 210.00 is 15341.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Harvard Apparatus Regenerative Technology and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harvard Apparatus Regenerative Technology's current PB Ratio is 210.00, which is 1552% above median its own 10-year median of 12.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology (HRGN) is currently considered Possible Value Trap. The stock's GF Value™ is $5.34, compared to a current price of $1.05 — trading 80.3% below its estimated fair value. The current PB Ratio is 210.00, which is 1552% above median its 10-year median of 12.71 and 15341.2% above the Consumer Packaged Goods industry median of 1.36. Harvard Apparatus Regenerative Technology's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current PB Ratio is 210.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Harvard Apparatus Regenerative Technology (HRGN) Overvalued in 2026?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology stock appears to be undervalued.
The current stock price of $1.05 is trading 80.3% below its estimated GF Value™ of $5.34.
GuruFocus considers Harvard Apparatus Regenerative Technology to be Possible Value Trap.
Key valuation signals for HRGN:
PB Ratio: 210.00 (1552% above median its 10-year median of 12.71)
GF Value™: $5.34 vs. price of $1.05 (80.3% below fair value)
Industry Position: 15341.2% above the Consumer Packaged Goods median (#1889 of 1894)
No single metric tells the full story. See the HRGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Harvard Apparatus Regenerative Technology Business Description
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
27GF Score
Get the complete analysis for HRGN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HRGN has been successfully added to your 
